Abstract
Patients affected by inflammatory bowel disease frequently suffer from thromboembolic complications and mesenteric microvascular occlusion could be involved in the pathogenesis of inflammatory bowel disease. Increased platelet counts and abnormal platelet function seem to play a crucial role in determining the hypercoagulable state observed in inflammatory bowel disease. Thrombopoietin is considered the primary regulator of thrombopoiesis and recent studies have investigated the role of thrombopoietin in inflammatory bowel disease. However, the available data are not conclusive. The aim of this study was to assess thrombopoietin serum levels in inflammatory bowel disease patients according to platelet counts, disease activity and previous thrombotic events.
Lingua originale | English |
---|---|
pagine (da-a) | 132-135 |
Numero di pagine | 4 |
Rivista | Hepato-Gastroenterology |
Volume | 50 |
Stato di pubblicazione | Pubblicato - 2003 |
Keywords
- Aged, 80 and over
- Colitis, Ulcerative
- Crohn Disease
- Middle Aged
- Platelet Count
- Risk Factors
- Severity of Illness Index
- Thromboembolism
- Thrombopoietin